[Federal Register: September 16, 2004 (Volume 69, Number 179)]
[Page 55824]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Advisory Committee on Special Studies Relating to the Possible 
Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch 
Hand Advisory Committee); Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee on Special Studies Relating 
to the Possible Long-Term Health Effects of Phenoxy Herbicides and 
Contaminants (Ranch Hand Advisory Committee).
    General Function of the Committee: To advise the Secretary and the 
Assistant Secretary for Health concerning its oversight of the conduct 
of the Ranch Hand study by the U.S. Air Force and provide scientific 
oversight of the Department of Veterans Affairs (VA) Army Chemical 
Corps Vietnam Veterans Health Study, and other studies in which the 
Secretary or the Assistant Secretary for Health believes involvement by 
the committee is desirable.
    Date and Time: The meeting will be held on September 22, 2004, 8 
a.m. to 4:30 p.m.
    Location: Food and Drug Administration, 5630 Fishers Lane, rm. 
1066, Rockville, MD 20857.
    Contact Person: Leonard Schechtman, National Center for 
Toxicological Research, Food and Drug Administration, 5600 Fishers 
Lane, rm. 16-85, Rockville, MD 20857, 301-827-6696, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512560. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The Air Force will present for review to The Ranch Hand 
Advisory Committee the following chapters from the ongoing study: 
Chapter 19, ``Immunology;'' chapter 8, ``Covariates;'' chapter 12, 
``Psychology;'' chapter 16, ``Hematology;'' chapter 15, 
``Cardiovascular;'' chapter 7, ``Statistical Methods;'' chapter 5, 
``Study Selection and Participation;'' and chapter 18, ``Endocrine.''
     Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by September 20, 
2004. Oral presentations from the public will be scheduled on September 
22, 2004, between approximately 12:15 p.m. and 12:40 p.m. Time allotted 
for each presentation may be limited.
     Those desiring to make formal oral presentations should notify the 
contact person before September 20, 2004, and submit a brief statement 
of the general nature of the evidence or arguments they wish to 
present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Leonard Schechtman 
at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: September 13, 2004.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 04-21009 Filed 9-14-04; 2:52 pm]